Login to Your Account



Two-Day Arthritis Adcom to Look at Cart and Horse

By Mari Serebrov
Washington Editor

Friday, July 19, 2013
In what could become a textbook example of putting the cart alongside the horse, the FDA will ask its Arthritis Advisory Committee Monday to consider whether the data are sufficient to make axial spondyloarthritis (SpA), as defined by the Assessment of Spondyloarthritis International Society (ASAS) criteria, a new indication for arthritis drugs.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription